MINT-TENOFOVIR

Identification of Mint-Tenofovir

No description

Google image searchProduct monograph

Active ingredient

tenofovir disoproxil fumarate, 300 MG

DIN: 02512939

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: MINT PHARMACEUTICALS INC

Date: 07-SEP-2021

ATC:

• J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
• J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
• J05AF — Nucleoside and nucleotide reverse transcriptase inhibitors (ATC, ATC/DDD)
• J05AF07 — TENOFOVIR DISOPROXIL (ATC/DDD)

Reference brand drug: Viread

Pharmaceutical standard: MFR

External Links for Mint-Tenofovir

Search on Google

• Mint-Tenofovir side effects
• Mint-Tenofovir dosage
• tenofovir disoproxil fumarate side effects
• tenofovir disoproxil fumarate dosage

Mint Pharmaceuticals Inc

Go to Mint website to see drug product details. Sometimes you can find mint-tenofovir photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.